Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1682 1683
This examiner grants 43% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19318202 | PRIMARY TEMPLATE-DIRECTED AMPLIFICATION AND METHODS THEREOF | Non-Final OA | BioSkryb Genomics, Inc. |
| 17541117 | CLOSED NUCLEIC ACID STRUCTURES | Final Rejection | GEN-PROBE INCORPORATED |
| 17266193 | METHOD FOR SYNTHESIZING SINGLE METAL NANOBRIDGED STRUCTURE AND METHOD FOR MANUFACTURING DNA POINT MUTATION DETECTION SENSOR BY USING SAME | Non-Final OA | Korea University Research and Business Foundation |
| 18251033 | METHOD FOR DETERMINING SENSITIVITY TO PARP INHIBITOR OR DNA DAMAGING AGENT USING NON-FUNCTIONAL TRANSCRIPTOME | Non-Final OA | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 17919152 | CRYBETAB2 PREDICTS POOR BREAST CANCER OUTCOME AND SENSITIZES TUMORS TO NUCLEOLIN AND CDK INHIBITION | Non-Final OA | The Johns Hopkins University |
| 19056221 | METHODS FOR METHYLATION ANALYSIS OF CELL-FREE DNA | Final Rejection | Hepta Bio, Inc. |
| 17555945 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID SEQUENCING | Non-Final OA | Illumina Cambridge Limited |
| 18060983 | COMPOSITIONS AND METHODS FOR DETECTING GENETIC FEATURES | Non-Final OA | Singular Genomics Systems, Inc. |
| 17786473 | METHOD OF MEASURING CELL-FREE DNA IN SURGICAL DRAIN FLUID TO SELECT ADJUVANT THERAPY | Non-Final OA | Washington University |
| 17666215 | IDENTIFICATION OF DRUGS TARGETING NON-GENETIC DRUG TOLERANCE PROGRAMS IN CANCER | Non-Final OA | ETH ZURICH |
| 18495951 | Multiple biomarkers for early diagnosis of multi cancer and uses thereof | Non-Final OA | NURIBIO CO., LTD |
| 18344616 | METHODS FOR CLASSIFICATION OF LIVER DISEASE | Non-Final OA | TENSOR BIOSCIENCES, INC. |
| 18254433 | METHODS FOR CLASSIFICATION OF LIVER DISEASE | Non-Final OA | TENSOR BIOSCIENCES, INC |
| 18035850 | Compositions and Methods for High Sensitivity Detection of Rare Mutations | Non-Final OA | CY Molecular Diagnostics, Inc. |
| 17641054 | BODY FLUID EXTRACT CONTAINING MICRO RNA | Non-Final OA | Craif Inc. |
| 17593447 | COMPOSITION OF PRIMERS FOR DETECTING HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION | Final Rejection | ECOLE NATIONALE VETERINAIRE D'ALFORT |
| 17993845 | MOLECULAR ANALYSES USING LONG CELL-FREE DNA MOLECULES FOR DISEASE CLASSIFICATION | Non-Final OA | Centre for Novostics Limited |
| 18009498 | ISOTHERMAL REAL-TIME PCR METHOD FOR DETERMINING PRESENCE OF A PRE-DETERMINED NUCLEIC ACID SEQUENCE IN ANIMAL SAMPLES | Non-Final OA | ENDER HOLDING AG |
| 18050795 | APPLICATION OF EPIGENETIC CHROMOSOMAL INTERACTIONS IN CANCER DIAGNOSTICS | Non-Final OA | Oxford BioDynamics, PLC |
| 17886778 | EARLY CANCER DIAGNOSIS METHOD AND DIAGNOSTIC KIT USING INTERFERON GAMMA GENE CONCENTRATION MEASUREMENT IN EXOSOMES | Final Rejection | Yeon Soo KIM |
| 17693129 | MULTIPLEXED GENOTYPING ASSAYS WITH A SINGLE PROBE USING FLUORESCENT AMPLITUDE TUNING | Final Rejection | GT MOLECULAR, LLC |
| 17635219 | PROBE-CAPTURE METHOD FOR TCR ALPHA AND BETA CHAIN VDJ-RECOVERY FROM OLIGO-DT REVERSE TRANSCRIBED RNA | Final Rejection | iRepertoire, Inc. |
| 17542078 | NUCLEIC ACID PROBES | Final Rejection | CYTOTEST INC. |
| 17160450 | Biological Sample Collectors and Handling Thereof | Final Rejection | Global Life Sciences Solutions Operations UK Ltd |
| 17097408 | LUNG CANCER DETERMINATIONS USING MIRNA | Final Rejection | Ugo Pastorino |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy